Recombinant Human FGF9
Catalog No : IGX-RP404
4512.77€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
Product name | Recombinant Human FGF9 | ||
---|---|---|---|
Catalog No | IGX-RP404 | ||
Supplier’s Catalog No | IGX-RP404 | ||
Supplier | ImuGeX | ||
Source antigen | E. coli | ||
Reactivity | Human | ||
Cross reactivity | |||
Applications | |||
Molecular weight | 23 |
Storage | -70°C | ||
---|---|---|---|
Other names | FGF-9, Glia-activating factor, GAF, Heparin-binding growth factor 9, HBGF-9<br/>Recombinant Human Fibroblast Growth Factor 9 (FGF9) | ||
Grade | Highly Purified | ||
Purity | >95% as determined by SDS-PAGE | ||
Form | Recombinant FGF-9 was lyophilized from a 0.2 μm filtered PBS solution. | ||
Reactivity life | 6 months | ||
Note | For reserch purpose only | ||
Purity | >95% as determined by SDS-PAGE | ||
Description | FGF-9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. FGF-9 induces osteoblast proliferation and new bone formation in a bone organ assay. FGF-9 is produced by many prostate cancer cells and contributes to prostate cancer-induced new bone formation. It also may participate in the osteoblastic progression of prostate cancer in bone. It is also an autocrine and/or paracrine neurotrophic factor that promotes the survival of motoneurons and upregulates choline acetyl-transferase activity. FGF-9 enhances survival of AChE-positive neurons and increases their mean soma size. It also up-regulates their choline acetyltransferase activity as potently as NGF and the effect is greater than that elicited by bFGF, CNTF, or GDNF. FGF-9 acts as a survival factor for neurons but does not promote neurite outgrowth. FGF-9 has been shown to mediate its effects by binding to FGF receptors. It efficiently activates the FGFR2c splice form of FGFR2 and the FGFR3b and FGFR3c splice isoforms of FGFR3. |
© 2020 Imugex All Rights Reserved